In our study, Among the 63 cases of breast invasive ductal cancer patients, 26 cases were positive for IGF2, and the rate of IGF-2 gene expression in the invasive breast cancer was higher than in the tumor-adjacent tissue. This evidence concerns the gene IGF2 and invasive breast carcinoma.